Aiming to fortify research potential in bio-medical science field, All India Institute of Medical Sciences (AIIMS) is joining hands with the University of Michigan of United States.
Dean of Research at AIIMS, N K Mehra informed that the two institutes will collaborate to work upon feasible researches related to the areas of cancer research, genetics and stem cell biology,trauma care and research in translational aspects of immunology.
The MoU will be signed on November 15, by the AIIMS Director, M C Mishra along with president of University of Michigan, Mary Sue Coleman in front of Union health minister, Ghulam Nabi Azad and Union health secretary, Keshav Desiraju.
A dynamic board of 21 scientists together with researchers also includes Joseph Kolas, senior associate dean for Education and Global initiatives and Professor Raghuvendra Krishnan, associate professor of surgery of UM Health Systems from the University of Michigan have arrived to India for this collaboration and agreement.
As Informed by N K Mehra, meeting for brainstorming with their staff over the topic of developing doable scientific collaboration in the areas of cancer research, trauma care and research in translational aspects of immunology, genetics and stem cell biology have already held.
Adding further that collaboration is yet only on a minor scale, now AIIMS is in procedure to expand it and maintain cooperation in bio-medical research. Advanced and detailed framework of the collaboration will be developed after signing the MoU.
Dr M C Mishra stated that The University of Michigan falls under the reputed state university medical schools and cooperation among these two esteemed institutions will absolutely aid in more development of research potential.
Lately, AIIMS joined with Australia's Alfred Health and Monash University as well, in order to reinforce trauma-care systems all across India.
The governments of Australia and India currently are spending $2.6 million dollars by means of Australia-India Strategic Research Fund Grand Challenge Scheme, to discover the most effective and excellent way to provide essential care to the injured people.
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.